Request Sample Inquiry
Precision Medicine Software Market

Precision medicine software Market

Precision medicine software Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

134

Base Year:

2022

Date

Mar - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1353

Segments Covered
  • By Delivery Mode By Delivery Mode On-premise Delivery Mode, Cloud-based Delivery Mode
  • By End User By End User Healthcare Providers, Research Centers and Academic Institutes, Pharmaceutical and Biotechnology Companies, Other End Users (non-profit organizations and diagnostic companies)
  • By Application By Application Oncology, Pharmacogenomics, Rare Diseases, Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1312.29 Million
Revenue 2030Revenue 2030: USD 3112.52 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 11.40%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Precision medicine software Market - Segment Analysis
    1. Overview
    2. Global Precision medicine software Market, 2016 - 2028 (USD Million)
    3. Global Precision medicine software Market - by Delivery Mode
      1. By On-premise Delivery Mode
      2. By Cloud-based Delivery Mode
    4. Global Precision medicine software Market - by End User
      1. By Healthcare Providers
      2. By Research Centers and Academic Institutes
      3. By Pharmaceutical and Biotechnology Companies
      4. By Other End Users (non-profit organizations and diagnostic companies)
    5. Global Precision medicine software Market - by Application
      1. By Oncology
      2. By Pharmacogenomics
      3. By Rare Diseases
      4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
    6. Global Precision medicine software Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Precision medicine software Market - Segment Analysis
    1. Overview
    2. North America Precision medicine software Market, 2016 - 2028 (USD Million)
    3. North America Precision medicine software Market, by Delivery Mode
      1. By On-premise Delivery Mode
      2. By Cloud-based Delivery Mode
    4. North America Precision medicine software Market, by End User
      1. By Healthcare Providers
      2. By Research Centers and Academic Institutes
      3. By Pharmaceutical and Biotechnology Companies
      4. By Other End Users (non-profit organizations and diagnostic companies)
    5. North America Precision medicine software Market, by Application
      1. By Oncology
      2. By Pharmacogenomics
      3. By Rare Diseases
      4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
    6. North America Precision medicine software Market, by Country
      1. U.S.
        1. U.S. Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. U.S. Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. U.S. Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      2. Canada
        1. Canada Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Canada Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Canada Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      3. Mexico
        1. Mexico Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Mexico Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Mexico Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
  5. Europe Precision medicine software Market - Segment Analysis
    1. Overview
    2. Europe Precision medicine software Market, 2016 - 2028 (USD Million)
    3. Europe Precision medicine software Market, by Delivery Mode
      1. By On-premise Delivery Mode
      2. By Cloud-based Delivery Mode
    4. Europe Precision medicine software Market, by End User
      1. By Healthcare Providers
      2. By Research Centers and Academic Institutes
      3. By Pharmaceutical and Biotechnology Companies
      4. By Other End Users (non-profit organizations and diagnostic companies)
    5. Europe Precision medicine software Market, by Application
      1. By Oncology
      2. By Pharmacogenomics
      3. By Rare Diseases
      4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
    6. Europe Precision medicine software Market, by Country
      1. Germany
        1. Germany Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Germany Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Germany Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      2. UK
        1. UK Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. UK Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. UK Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      3. France
        1. France Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. France Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. France Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      4. Spain
        1. Spain Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Spain Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Spain Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      5. Italy
        1. Italy Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Italy Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Italy Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      6. BENELUX
        1. BENELUX Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. BENELUX Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. BENELUX Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      7. Rest of Europe
        1. Rest Of Europe Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Rest Of Europe Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Rest Of Europe Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
  6. Asia Pacific Precision medicine software Market - Segment Analysis
    1. Overview
    2. Asia Pacific Precision medicine software Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Precision medicine software Market, by Delivery Mode
      1. By On-premise Delivery Mode
      2. By Cloud-based Delivery Mode
    4. Asia Pacific Precision medicine software Market, by End User
      1. By Healthcare Providers
      2. By Research Centers and Academic Institutes
      3. By Pharmaceutical and Biotechnology Companies
      4. By Other End Users (non-profit organizations and diagnostic companies)
    5. Asia Pacific Precision medicine software Market, by Application
      1. By Oncology
      2. By Pharmacogenomics
      3. By Rare Diseases
      4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
    6. Asia Pacific Precision medicine software Market, by Country
      1. China
        1. China Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. China Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. China Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      2. Japan
        1. Japan Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Japan Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Japan Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      3. India
        1. India Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. India Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. India Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      4. South Korea
        1. South Korea Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. South Korea Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. South Korea Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      5. South East Asia
        1. South East Asia Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. South East Asia Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. South East Asia Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Rest of Asia Pacific Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Rest of Asia Pacific Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
  7. Latin America Precision medicine software Market - Segment Analysis
    1. Overview
    2. Latin America Precision medicine software Market, 2016 - 2028 (USD Million)
    3. Latin America Precision medicine software Market, by Delivery Mode
      1. By On-premise Delivery Mode
      2. By Cloud-based Delivery Mode
    4. Latin America Precision medicine software Market, by End User
      1. By Healthcare Providers
      2. By Research Centers and Academic Institutes
      3. By Pharmaceutical and Biotechnology Companies
      4. By Other End Users (non-profit organizations and diagnostic companies)
    5. Latin America Precision medicine software Market, by Application
      1. By Oncology
      2. By Pharmacogenomics
      3. By Rare Diseases
      4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
    6. Latin America Precision medicine software Market, by Country
      1. Brazil
        1. Brazil Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Brazil Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Brazil Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      2. Argentina
        1. Argentina Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Argentina Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Argentina Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      3. Rest of Latin America
        1. Rest of Latin America Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Rest of Latin America Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Rest of Latin America Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
  8. Middle East & Africa Precision medicine software Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Precision medicine software Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Precision medicine software Market, by Delivery Mode
      1. By On-premise Delivery Mode
      2. By Cloud-based Delivery Mode
    4. Middle East & Africa Precision medicine software Market, by End User
      1. By Healthcare Providers
      2. By Research Centers and Academic Institutes
      3. By Pharmaceutical and Biotechnology Companies
      4. By Other End Users (non-profit organizations and diagnostic companies)
    5. Middle East & Africa Precision medicine software Market, by Application
      1. By Oncology
      2. By Pharmacogenomics
      3. By Rare Diseases
      4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
    6. Middle East & Africa Precision medicine software Market, by Country
      1. GCC Countries
        1. GCC Countries Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. GCC Countries Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. GCC Countries Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      2. South Africa
        1. South Africa Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. South Africa Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. South Africa Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Precision medicine software Market, By Delivery Mode
          1. By On-premise Delivery Mode
          2. By Cloud-based Delivery Mode
        2. Rest of Middle East & Africa Precision medicine software Market, By End User
          1. By Healthcare Providers
          2. By Research Centers and Academic Institutes
          3. By Pharmaceutical and Biotechnology Companies
          4. By Other End Users (non-profit organizations and diagnostic companies)
        3. Rest of Middle East & Africa Precision medicine software Market, By Application
          1. By Oncology
          2. By Pharmacogenomics
          3. By Rare Diseases
          4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Syapse Inc.
    2. 2bprecise
    3. LLC
    4. Fabric Genomics Inc.
    5. Foundation Medicine Inc.
    6. Sophia Genetics Sa
    7. Pieriandx Inc.
    8. N-Of-One Inc. (A Subsidiary of Qiagen N.V.)
    9. Human Longevity Inc.
    10. Translational Software Inc.
    11. Sunquest Information Systems Inc.
    12. Gene42 Inc.
    13. Lifeomic Health
    14. LLC
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 08-Mar-2022
Precision medicine software market Market to Reach 2288.82 USD Million by 2028
FAQ
Frequently Asked Question

  • The global Precision medicine software valued at USD 1312.29 Million in 2022 and is expected to reach USD 3112.52 Million in 2030 growing at a CAGR of 11.40%.

  • The prominent players in the market are Syapse, Inc., 2bprecise, LLC, Fabric Genomics, Inc., Foundation Medicine, Inc., Sophia Genetics Sa, Pieriandx, Inc., N-Of-One, Inc. (A Subsidiary of Qiagen N.V.), Human Longevity, Inc., Translational Software Inc., Sunquest Information Systems, Inc., Gene42, Inc., Lifeomic Health, LLC.

  • The market is project to grow at a CAGR of 11.40% between 2023 and 2030.

  • The driving factors of the Precision medicine software include

    • Growing emphasis on delivering personalized medicine in hospitals

  • North America was the leading regional segment of the Precision medicine software in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy